FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1883811000001101: Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25222101000001119 Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
111558001000001118 Dyazide 50mg/25mg tablets (Advanz Pharma) 30 tablet 2 x 15 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Is a Co-triamterzide 50mg/25mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Is pack of Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) false Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has active ingredient Triamterene false Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has AMP Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Triamterene true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dyazide 50mg/25mg tablets (Goldshield Healthcare Ltd) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start